2 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 2 |
Follow 64Cu-LLP2A: new trials by email Literature Review of 64Cu-LLP2A trials Research Report on 64Cu-LLP2A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 64Cu-LLP2A for Imaging Hematologic Malignancies 64Cu-LLP2A, PET/CT - Multiple Myeloma, Low-Grade Lymphoma | Early Phase 1 | Terminated | Washington University School of Medicine | 21 | 2025-03-20 | 2026-10-16 |
| 64Cu-LLP2A for Imaging Multiple Myeloma 64Cu-LLP2A, PET/MR, Blood samples for serum stability - Multiple Myeloma | Early Phase 1 | Terminated | Washington University School of Medicine | 10 | 2018-11-20 | 2024-11-12 |
Multiple Myeloma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1)
Washington University School of Medicine (2)
United States (2)
R42CA257797 (1)